chr19-50281720-G-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001145809.2(MYH14):c.4417G>A(p.Val1473Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000357 in 1,612,528 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001145809.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MYH14 | NM_001145809.2 | c.4417G>A | p.Val1473Met | missense_variant | 33/43 | ENST00000642316.2 | |
MYH14 | NM_001077186.2 | c.4318G>A | p.Val1440Met | missense_variant | 32/42 | ||
MYH14 | NM_024729.4 | c.4294G>A | p.Val1432Met | missense_variant | 31/41 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MYH14 | ENST00000642316.2 | c.4417G>A | p.Val1473Met | missense_variant | 33/43 | NM_001145809.2 |
Frequencies
GnomAD3 genomes AF: 0.000965 AC: 147AN: 152254Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000434 AC: 105AN: 241862Hom.: 0 AF XY: 0.000407 AC XY: 54AN XY: 132722
GnomAD4 exome AF: 0.000293 AC: 428AN: 1460156Hom.: 0 Cov.: 32 AF XY: 0.000324 AC XY: 235AN XY: 726400
GnomAD4 genome AF: 0.000965 AC: 147AN: 152372Hom.: 0 Cov.: 33 AF XY: 0.000926 AC XY: 69AN XY: 74516
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 11, 2021 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 08, 2016 | p.Val1473Met in exon 33 of MYH14: This variant is not expected to have clinical significance because it has been identified in 0.3% (21/7786) of African chromos omes, including 1 homozygote, by the Exome Aggregation Consortium (ExAC, http:// exac.broadinstitute.org; dbSNP rs112716976). - |
Autosomal dominant nonsyndromic hearing loss 4A Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. - |
MYH14-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 02, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at